These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28754921)

  • 1. Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations.
    Bompard A; Da DF; Yerbanga RS; Biswas S; Kapulu M; Bousema T; Lefèvre T; Cohuet A; Churcher TS
    Sci Rep; 2017 Jul; 7(1):6766. PubMed ID: 28754921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Characterization and Comparison of
    Nikolaeva D; Illingworth JJ; Miura K; Alanine DGW; Brian IJ; Li Y; Fyfe AJ; Da DF; Cohuet A; Long CA; Draper SJ; Biswas S
    Mol Cell Proteomics; 2020 Jan; 19(1):155-166. PubMed ID: 29089373
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural vaccinology of malaria transmission-blocking vaccines.
    Patel PN; Tolia N
    Expert Rev Vaccines; 2021 Feb; 20(2):199-214. PubMed ID: 33430656
    [No Abstract]   [Full Text] [Related]  

  • 4. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination.
    Duffy PE
    Expert Rev Vaccines; 2021 Feb; 20(2):185-198. PubMed ID: 33478283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.
    Mlambo G; Maciel J; Kumar N
    Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens.
    Eldering M; Bompard A; Miura K; Stone W; Morlais I; Cohuet A; van Gemert GJ; Brock PM; Rijpma SR; van de Vegte-Bolmer M; Graumans W; Siebelink-Stoter R; Da DF; Long CA; Morin MJ; Sauerwein RW; Churcher TS; Bousema T
    Parasit Vectors; 2017 Oct; 10(1):489. PubMed ID: 29041962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.
    Coban C; Philipp MT; Purcell JE; Keister DB; Okulate M; Martin DS; Kumar N
    Infect Immun; 2004 Jan; 72(1):253-9. PubMed ID: 14688103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.
    Kapulu MC; Da DF; Miura K; Li Y; Blagborough AM; Churcher TS; Nikolaeva D; Williams AR; Goodman AL; Sangare I; Turner AV; Cottingham MG; Nicosia A; Straschil U; Tsuboi T; Gilbert SC; Long CA; Sinden RE; Draper SJ; Hill AV; Cohuet A; Biswas S
    Sci Rep; 2015 Jun; 5():11193. PubMed ID: 26063320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.
    McGuire KA; Miura K; Wiethoff CM; Williamson KC
    Malar J; 2017 Jun; 16(1):254. PubMed ID: 28619071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
    Chan JA; Wetzel D; Reiling L; Miura K; Drew DR; Gilson PR; Anderson DA; Richards JS; Long CA; Suckow M; Jenzelewski V; Tsuboi T; Boyle MJ; Piontek M; Beeson JG
    PLoS One; 2019; 14(9):e0221733. PubMed ID: 31504038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of domains within Pfs230 that elicit transmission blocking antibody responses.
    Tachibana M; Miura K; Takashima E; Morita M; Nagaoka H; Zhou L; Long CA; Richter King C; Torii M; Tsuboi T; Ishino T
    Vaccine; 2019 Mar; 37(13):1799-1806. PubMed ID: 30824357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of exposure to mosquito transmission-blocking antibodies on Plasmodium falciparum population genetic structure.
    Sandeu MM; Abate L; Tchioffo MT; Bayibéki AN; Awono-Ambéné PH; Nsango SE; Chesnais CB; Dinglasan RR; de Meeûs T; Morlais I
    Infect Genet Evol; 2016 Nov; 45():138-144. PubMed ID: 27566334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity.
    Bustamante PJ; Woodruff DC; Oh J; Keister DB; Muratova O; Williamson KC
    Parasite Immunol; 2000 Aug; 22(8):373-80. PubMed ID: 10972844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.
    Miura K; Swihart BJ; Deng B; Zhou L; Pham TP; Diouf A; Burton T; Fay MP; Long CA
    Vaccine; 2016 Jul; 34(35):4145-4151. PubMed ID: 27372156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum.
    Li T; Eappen AG; Richman AM; Billingsley PF; Abebe Y; Li M; Padilla D; Rodriguez-Barraquer I; Sim BK; Hoffman SL
    Malar J; 2015 Apr; 14():150. PubMed ID: 25890243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.
    Brickley EB; Coulibaly M; Gabriel EE; Healy SA; Hume JCC; Sagara I; Traore SF; Doumbo O; Duffy PE
    Vaccine; 2016 Nov; 34(48):5863-5870. PubMed ID: 27789147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.
    Kapoor N; Vanjak I; Rozzelle J; Berges A; Chan W; Yin G; Tran C; Sato AK; Steiner AR; Pham TP; Birkett AJ; Long CA; Fairman J; Miura K
    Biochemistry; 2018 Feb; 57(5):516-519. PubMed ID: 29323879
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Singh SK; Thrane S; Chourasia BK; Teelen K; Graumans W; Stoter R; van Gemert GJ; van de Vegte-Bolmer MG; Nielsen MA; Salanti A; Sander AF; Sauerwein RW; Jore MM; Theisen M
    Front Immunol; 2019; 10():1256. PubMed ID: 31231386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.